Skip to main content
. Author manuscript; available in PMC: 2019 Mar 25.
Published in final edited form as: Biochem Biophys Res Commun. 2018 Jun 15;503(2):684–690. doi: 10.1016/j.bbrc.2018.06.061

Fig. 2. Rosiglitazone Inhibits Pulmonary Granuloma Formation 20 days post MWCNT Instillation.

Fig. 2.

Quantitative analysis of H&E stained lung tissue was utilized to evaluate (A) the average number of granulomas, (B) average granuloma size, (C) and total carbon deposition in MWCNT-instilled animals receiving normal chow or rosiglitazone (6 mg/kg). Evaluation of (D) mediastinal lymph node volume and (E) BAL-fluid protein concentration in vehicle and MWCNT-instilled animals receiving normal chow or rosiglitazone (6 mg/ kg). ★p < 0.05, n ≥ 5/treatment.